GYRE THERAPEUTICS

GYRE THERAPEUTICS Share · US4037831033 · GYRE · A3EE5F (XNCM) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of GYRE THERAPEUTICS
Analyst Grade Summary
gauge-img
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
0
9
4
0
0
No Price
01.05.2026 20:40
Current Prices from GYRE THERAPEUTICS
ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
GYRE
USD
01.05.2026 20:40
7,85 USD
-14,52 USD
-64,91 %
IEXG: IEX
IEX
CBIO
USD
01.05.2026 19:59
18,07 USD
-4,30 USD
-19,22 %
XDUS: Düsseldorf
Düsseldorf
GTIRSN33.DUSB
EUR
30.04.2026 17:31
6,40 EUR
-
XDQU: Quotrix
Quotrix
GTIRSN33.DUSD
EUR
30.04.2026 05:27
6,30 EUR
-
ESG Risk Rating
B Good
Share Float & Liquidity
Free Float 77,30 %
Shares Float 21,3 M
Shares Outstanding 27,56 M
Company Profile for GYRE THERAPEUTICS Share
Crescent Biopharma, Inc., an oncology company, develops therapies for cancer patients. Its pipeline includes a PD-1 x VEGF bispecific antibody, as well as novel antibody-drug conjugates to treat solid tumors. The company is headquartered in Waltham, Massachusetts.

Company Data

Name GYRE THERAPEUTICS
Company Crescent Biopharma, Inc.
Symbol GYRE
Website https://www.gyretx.com
Primary Exchange XNCM Frankfurt
WKN A3EE5F
ISIN US4037831033
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Joshua T. Brumm
Market Capitalization 745 Mio
Country United States of America
Currency EUR
Employees 0,0 T
Address 300 5th Avenue, 02451 Waltham
IPO Date 2014-01-10
Dividends from 'GYRE THERAPEUTICS'
Ex-Date Dividend per Share
13.01.2023 0,24 USD
13.01.2023 0,24 USD
21.09.2022 1,43 USD
21.09.2022 1,43 USD
02.09.2022 1,43 USD
20.08.2015 0,57 USD
20.08.2015 0,14 USD

Stock Splits

Date Split
16.06.2025 1:100
31.10.2023 1:15
13.01.2023 2:1
13.02.2017 1:15
21.08.2015 1:7
06.02.2006 1:15

ID Changes

Date From To
31.10.2023 CBIO GYRE
07.11.2015 TRGT CBIO
16.06.2025 GLYC CBIO

Ticker Symbols

Name Symbol
Düsseldorf GTIRSN33.DUSB
Frankfurt L9S.F
NASDAQ CBIO
NASDAQ GYRE
Quotrix GTIRSN33.DUSD
More Shares
Investors who hold GYRE THERAPEUTICS also have the following shares in their portfolio:
Magellanic Cloud Ltd.
Magellanic Cloud Ltd. Share
OMEGA ALPHA SPAC - CLASS A
OMEGA ALPHA SPAC - CLASS A Share